Core Viewpoint - Hillenbrand, Inc. reported a decline in financial performance for the fiscal second quarter of 2025, primarily due to lower capital equipment volume and increased macroeconomic uncertainty, leading to an adjusted outlook for the remainder of the fiscal year [2][3][7]. Financial Performance Summary - Net revenue for the second quarter was 785.3 million in the prior year, mainly due to lower capital equipment volume [3][7]. - GAAP net loss attributable to Hillenbrand was (0.58) per share, compared to a profit of 0.09 per share, in the prior year [4][7]. - Adjusted EBITDA was 122.6 million year-over-year, primarily due to lower volume and cost inflation [5][7]. - Adjusted diluted EPS was 0.76 in the prior year [5][7]. Segment Performance - Advanced Process Solutions (APS) segment net revenue was 559.2 million, primarily due to lower capital equipment volume [6][8]. - Molding Technology Solutions (MTS) segment net revenue was 226.1 million, driven by unfavorable foreign currency exchange rates [10][11]. Backlog and Future Outlook - Total backlog decreased by 15% year-over-year to 2.555 billion and 1.3 million, a decrease of 59% from 1.46 billion, with a net debt to pro forma adjusted EBITDA ratio of 3.4x [14][38]. Recent Transactions - The company completed the sale of a majority stake in the Milacron injection molding and extrusion business on March 31, 2025, generating net proceeds of approximately 245 million, expected to close in late fiscal third quarter or early fiscal fourth quarter 2025 [15].
Hillenbrand Reports Fiscal Second Quarter 2025 Results